Home / ABCL : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ABCL make money? Does ABCL have pricing power? What's the Earnings Whisper? Will ABCL profit more as the business scales? What is ABCL's management track record? Is ABCL's current price justified?

AbCellera Biologics Inc.

$11.2 +$7.77 (+226.38%)

NASDAQ · 14 Sep 2026 17:31 UTC

Previous Close

$10.89

Day Range

$10.66$11.3

Year Range

$2.75$12.58

Market Cap

3.42B

AVG Volume

7.81M

Trailing/Forward PE

-20.56/-

PEG ratio

-2.21

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

NASDAQ

Revenue (USD) · TTM

ABCL Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	66.17M
26 Q1	79.21M
25 Q4	75.13M
25 Q3	35.32M
25 Q2	32.88M
25 Q1	23.11M
24 Q4	28.83M
24 Q3	32.96M
24 Q2	33.05M
24 Q1	35.79M

Net Income (USD) · TTM

ABCL Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-164.66M
26 Q1	-143.96M
25 Q4	-146.41M
25 Q3	-171.68M
25 Q2	-165.66M
25 Q1	-167.87M
24 Q4	-162.86M
24 Q3	-175.8M
24 Q2	-153.3M
24 Q1	-146.9M

Operating Income (USD) · TTM

ABCL Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-225.16M
26 Q1	-211.96M
25 Q4	-217.1M
25 Q3	-261.28M
25 Q2	-278.66M
25 Q1	-322.53M
24 Q4	-314.77M
24 Q3	-308.06M
24 Q2	-269.29M
24 Q1	-227.23M

EBITDA (USD) · TTM

ABCL EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-160.3M
26 Q1	-157.61M
25 Q4	-168.63M
25 Q3	-212.36M
25 Q2	-197.92M
25 Q1	-211.2M
24 Q4	-204.15M
24 Q3	-202.41M
24 Q2	-195.18M
24 Q1	-182.63M

Cash Flows (USD) · TTM

ABCL Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-179.46M
26 Q1	-189.23M
25 Q4	-174.07M
25 Q3	-153.11M
25 Q2	-139.17M
25 Q1	-142.66M
24 Q4	-186.32M
24 Q3	-196.73M
24 Q2	-169.58M
24 Q1	-127.86M

EPS (USD) · TTM

ABCL EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.54
26 Q1	-0.48
25 Q4	-0.49
25 Q3	-0.58
25 Q2	-0.56
25 Q1	-0.57
24 Q4	-0.56
24 Q3	-0.6
24 Q2	-0.53
24 Q1	-0.51

Expenses (USD) · TTM

ABCL Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	287.25M
26 Q1	299.85M
25 Q4	311.04M
25 Q3	316.55M
25 Q2	309.47M
25 Q1	318.96M
24 Q4	330.9M
24 Q3	332.16M
24 Q2	326.41M
24 Q1	325.54M

Shares Outstanding (USD) · TTM

ABCL Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-51.1M
26 Q1	-53.02M
25 Q4	-55.79M
25 Q3	-56.53M
25 Q2	-42.64M
25 Q1	-28.43M
24 Q4	-31.05M
24 Q3	-33.86M
24 Q2	-49.72M
24 Q1	-49.72M

Employee Count

ABCL Employee Count by quarter
Period	Employee Count
2025	562
2024	596
2023	586
2022	495
2021	386
2020	206

PE Ratio

ABCL PE Ratio by quarter
Period	PE Ratio
Apr 23	12.25
Apr 23	13.03
Apr 23	13.33
Apr 23	13.08
Mar 23	13.62
Mar 23	13.26
Mar 23	13.35
Mar 23	13.64
Mar 23	15.14
Feb 23	15.12
Feb 23	11.02
Feb 23	11.29
Feb 23	12.84
Jan 23	12.36
Jan 23	11.88
Jan 23	11.92
Jan 23	10.93
Dec 22	11.64
Dec 22	11.87
Dec 22	11.73
Dec 22	12.03
Dec 22	14.6
Nov 22	15.53
Nov 22	16.27
Nov 22	15.6
Nov 22	16.92
Oct 22	16.64
Oct 22	14.65
Oct 22	14.69
Oct 22	15.27
Sep 22	14.05
Sep 22	13.07
Sep 22	14.71
Sep 22	15.91
Sep 22	15.4
Aug 22	16
Aug 22	16.26
Aug 22	19.44
Aug 22	15.69
Jul 22	13.92
Jul 22	13.96
Jul 22	14.61
Jul 22	16.05
Jul 22	14.75
Jun 22	14.76
Jun 22	14.03
Jun 22	11.56
Jun 22	10.45
May 22	10.95
May 22	10.95
May 22	10.02
May 22	13.57
Apr 22	13.99
Apr 22	14.55
Apr 22	16.39
Apr 22	16.48
Apr 22	18.47
Mar 22	17.4
Mar 22	16.1
Mar 22	14.13
Mar 22	15.55
Feb 22	16.28
Feb 22	12.14
Feb 22	12.77
Feb 22	12.32
Jan 22	11.38
Jan 22	11.45
Jan 22	13.32
Jan 22	15.66
Dec 21	18.95
Dec 21	19.78
Dec 21	19.85
Dec 21	18.51
Dec 21	18.58
Nov 21	18.54
Nov 21	20.93
Nov 21	19.9
Nov 21	17.92
Oct 21	18.66
Oct 21	18.97
Oct 21	18.44
Oct 21	18.25
Oct 21	20.43
Sep 21	25.12
Sep 21	24.18
Sep 21	22.55
Sep 21	22.26
Aug 21	20.88
Aug 21	19.05
Aug 21	21.25
Aug 21	16.95
Jul 21	17.17
Jul 21	17.88
Jul 21	19.17
Jul 21	21.93
Jul 21	23.19
Jun 21	23.48
Jun 21	26.25
Jun 21	29.32
Jun 21	29.4

Free Cash Flow Yield

ABCL Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-5.39%
Sep 26	-5.14%
Aug 26	-5.17%
Aug 26	-5.19%
Aug 26	-5.16%
Aug 26	-8.47%
Jul 26	-10.93%
Jul 26	-11.76%
Jul 26	-9.65%
Jul 26	-9.18%
Jul 26	-7.7%
Jun 26	-8.46%
Jun 26	-11.29%
Jun 26	-11.92%
Jun 26	-11.11%
May 26	-10.12%
May 26	-12.01%
May 26	-15.27%
May 26	-11.12%
May 26	-13.15%
Apr 26	-14.04%
Apr 26	-14.53%
Apr 26	-16.46%
Apr 26	-16.55%
Mar 26	-17.82%
Mar 26	-17.14%
Mar 26	-16.7%
Mar 26	-16.89%
Feb 26	-16.14%
Feb 26	-16.85%
Feb 26	-16.53%
Feb 26	-16.21%
Jan 26	-14.15%
Jan 26	-12.08%
Jan 26	-12.43%
Jan 26	-11.72%
Jan 26	-14.94%
Dec 25	-14.31%
Dec 25	-14.23%
Dec 25	-14.15%
Dec 25	-14.39%
Nov 25	-13.73%
Nov 25	-14.6%
Nov 25	-13.88%
Nov 25	-13.1%
Oct 25	-8.4%
Oct 25	-8.24%
Oct 25	-8.34%
Oct 25	-8.43%
Oct 25	-7.9%
Sep 25	-9.84%
Sep 25	-10.34%
Sep 25	-10.43%
Sep 25	-11.05%
Aug 25	-11.15%
Aug 25	-10.62%
Aug 25	-10.16%
Aug 25	-10.97%
Aug 25	-11.3%
Jul 25	-9.38%
Jul 25	-10.7%
Jul 25	-11.95%
Jul 25	-12.61%
Jun 25	-13.27%
Jun 25	-14.05%
Jun 25	-14.98%
Jun 25	-19.64%
May 25	-23.72%
May 25	-24.33%
May 25	-23.61%
May 25	-23.61%
May 25	-26.24%
Apr 25	-24.61%
Apr 25	-26.13%
Apr 25	-26.35%
Apr 25	-30.26%
Mar 25	-27.38%
Mar 25	-25.92%
Mar 25	-25.1%
Mar 25	-27.14%
Feb 25	-24.42%
Feb 25	-22.02%
Feb 25	-20.4%
Feb 25	-21.52%
Jan 25	-21.05%
Jan 25	-19.17%
Jan 25	-22.46%
Jan 25	-22.85%
Jan 25	-21.32%
Dec 24	-22.31%
Dec 24	-23.41%
Dec 24	-23.74%
Dec 24	-22.24%
Nov 24	-22.17%
Nov 24	-24.17%
Nov 24	-25.18%
Nov 24	-24.71%
Nov 24	-21.11%
Oct 24	-21.19%
Oct 24	-20.08%

Price to Sales

ABCL Price to Sales by quarter
Period	Price to Sales
Sep 26	50.29
Sep 26	52.78
Aug 26	52.41
Aug 26	52.27
Aug 26	52.55
Aug 26	32
Jul 26	21.85
Jul 26	20.32
Jul 26	24.76
Jul 26	26.02
Jul 26	31.03
Jun 26	28.24
Jun 26	21.16
Jun 26	20.05
Jun 26	21.5
May 26	23.61
May 26	19.9
May 26	15.65
May 26	20.83
May 26	17.61
Apr 26	16.5
Apr 26	15.94
Apr 26	14.08
Apr 26	14
Mar 26	13
Mar 26	13.52
Mar 26	13.88
Mar 26	13.72
Feb 26	14.35
Feb 26	25.72
Feb 26	26.23
Feb 26	26.74
Jan 26	30.63
Jan 26	35.87
Jan 26	34.86
Jan 26	36.97
Jan 26	29.02
Dec 25	30.29
Dec 25	30.46
Dec 25	30.63
Dec 25	30.12
Nov 25	31.56
Nov 25	29.7
Nov 25	31.22
Nov 25	33.08
Oct 25	50.39
Oct 25	51.39
Oct 25	50.76
Oct 25	50.21
Oct 25	53.57
Sep 25	43.04
Sep 25	40.95
Sep 25	40.59
Sep 25	38.32
Aug 25	37.95
Aug 25	39.86
Aug 25	41.68
Aug 25	38.59
Aug 25	54.61
Jul 25	65.81
Jul 25	57.7
Jul 25	51.64
Jul 25	48.94
Jun 25	46.49
Jun 25	43.92
Jun 25	41.21
Jun 25	31.42
May 25	26.02
May 25	25.37
May 25	26.14
May 25	26.14
May 25	24.62
Apr 25	26.26
Apr 25	24.72
Apr 25	24.52
Apr 25	21.35
Mar 25	23.6
Mar 25	24.93
Mar 25	25.75
Mar 25	23.81
Feb 25	26.46
Feb 25	27.1
Feb 25	29.25
Feb 25	27.73
Jan 25	28.36
Jan 25	31.13
Jan 25	26.57
Jan 25	26.12
Jan 25	28
Dec 24	26.75
Dec 24	25.49
Dec 24	25.14
Dec 24	26.83
Nov 24	26.92
Nov 24	24.69
Nov 24	23.7
Nov 24	24.15
Nov 24	24.3
Oct 24	24.21
Oct 24	25.55

EV/EBITDA

ABCL EV/EBITDA by quarter
Period	EV/EBITDA
Apr 23	4.12
Apr 23	4.56
Apr 23	4.74
Apr 23	4.6
Mar 23	4.91
Mar 23	4.7
Mar 23	4.75
Mar 23	4.92
Mar 23	5.78
Feb 23	5.77
Feb 23	5.18
Feb 23	5.37
Feb 23	6.39
Jan 23	6.07
Jan 23	5.75
Jan 23	5.78
Jan 23	5.12
Dec 22	5.59
Dec 22	5.75
Dec 22	5.65
Dec 22	5.85
Dec 22	7.56
Nov 22	8.17
Nov 22	8.66
Nov 22	8.22
Nov 22	7.78
Oct 22	7.6
Oct 22	6.31
Oct 22	6.34
Oct 22	6.72
Sep 22	5.92
Sep 22	5.29
Sep 22	6.35
Sep 22	7.13
Sep 22	6.8
Aug 22	7.18
Aug 22	7.35
Aug 22	9.41
Aug 22	7.92
Jul 22	6.75
Jul 22	6.78
Jul 22	7.21
Jul 22	8.16
Jul 22	7.3
Jun 22	7.31
Jun 22	6.83
Jun 22	5.2
Jun 22	4.48
May 22	4.8
May 22	4.8
May 22	4.19
May 22	5.79
Apr 22	6.05
Apr 22	6.41
Apr 22	7.58
Apr 22	7.64
Apr 22	8.9
Mar 22	8.22
Mar 22	7.4
Mar 22	6.15
Mar 22	7.05
Feb 22	7.51
Feb 22	5.94
Feb 22	6.37
Feb 22	6.07
Jan 22	5.42
Jan 22	5.47
Jan 22	6.74
Jan 22	8.35
Dec 21	10.59
Dec 21	11.16
Dec 21	11.2
Dec 21	10.29
Dec 21	10.34
Nov 21	10.31
Nov 21	11.95
Nov 21	11.24
Nov 21	10.2
Oct 21	10.71
Oct 21	10.93
Oct 21	10.56
Oct 21	10.43
Oct 21	11.94
Sep 21	15.22
Sep 21	14.56
Sep 21	13.43
Sep 21	13.22
Aug 21	12.26
Aug 21	10.98
Aug 21	12.52
Aug 21	10.07
Jul 21	10.23
Jul 21	10.73
Jul 21	11.65
Jul 21	13.62
Jul 21	14.51
Jun 21	14.72
Jun 21	16.7
Jun 21	18.88
Jun 21	18.94

Price/Operating Cashflow

ABCL Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Feb 24	235.64
Feb 24	225.49
Feb 24	221.07
Jan 24	234.75
Jan 24	231.22
Jan 24	237.84
Jan 24	257.7
Dec 23	251.96
Dec 23	251.08
Dec 23	239.61
Dec 23	214.9
Dec 23	213.13
Nov 23	195.48
Nov 23	197.25
Nov 23	178.27
Nov 23	207.39
Jul 23	16.82
Jul 23	17.17
Jul 23	15.66
Jul 23	14.24
Jun 23	14.13
Jun 23	15.99
Jun 23	16.58
Jun 23	15.51
Jun 23	14.85
May 23	14.87
May 23	12.77
May 23	12.55
May 23	13.1
Apr 23	7.04
Apr 23	7.49
Apr 23	7.66
Apr 23	7.52
Mar 23	7.83
Mar 23	7.62
Mar 23	7.67
Mar 23	7.84
Mar 23	8.7
Feb 23	8.69
Feb 23	11.99
Feb 23	12.29
Feb 23	13.98
Jan 23	13.45
Jan 23	12.93
Jan 23	12.98
Jan 23	11.89
Dec 22	12.66
Dec 22	12.91
Dec 22	12.76
Dec 22	13.09
Dec 22	15.89
Nov 22	16.9
Nov 22	17.7
Nov 22	16.98
Nov 22	9.71
Oct 22	9.55
Oct 22	8.41
Oct 22	8.43
Oct 22	8.77
Sep 22	8.07
Sep 22	7.5
Sep 22	8.44
Sep 22	9.13
Sep 22	8.84
Aug 22	9.18
Aug 22	9.33
Aug 22	11.16
Aug 22	13.42
Jul 22	11.91
Jul 22	11.94
Jul 22	12.5
Jul 22	13.73
Jul 22	12.62
Jun 22	12.63
Jun 22	12
Jun 22	9.89
Jun 22	8.94
May 22	9.37
May 22	9.37
May 22	8.57
May 22	8.37
Apr 22	8.63
Apr 22	8.98
Apr 22	10.11
Apr 22	10.17
Apr 22	11.4
Mar 22	10.73
Mar 22	9.93
Mar 22	8.72
Mar 22	9.6
Feb 22	10.05
Feb 22	9.57
Feb 22	10.07
Feb 22	9.71
Jan 22	8.97
Jan 22	9.02
Jan 22	10.5
Jan 22	12.34
Dec 21	14.93
Dec 21	15.59

Price to Book

ABCL Price to Book by quarter
Period	Price to Book
Sep 26	3.71
Sep 26	3.9
Aug 26	3.87
Aug 26	3.86
Aug 26	3.88
Aug 26	2.36
Jul 26	1.84
Jul 26	1.72
Jul 26	2.09
Jul 26	2.2
Jul 26	2.62
Jun 26	2.38
Jun 26	1.79
Jun 26	1.69
Jun 26	1.82
May 26	1.99
May 26	1.68
May 26	1.32
May 26	1.62
May 26	1.37
Apr 26	1.28
Apr 26	1.24
Apr 26	1.09
Apr 26	1.09
Mar 26	1.01
Mar 26	1.05
Mar 26	1.08
Mar 26	1.07
Feb 26	1.12
Feb 26	0.94
Feb 26	0.96
Feb 26	0.98
Jan 26	1.12
Jan 26	1.31
Jan 26	1.28
Jan 26	1.35
Jan 26	1.06
Dec 25	1.11
Dec 25	1.12
Dec 25	1.12
Dec 25	1.1
Nov 25	1.16
Nov 25	1.09
Nov 25	1.14
Nov 25	1.21
Oct 25	1.65
Oct 25	1.68
Oct 25	1.66
Oct 25	1.64
Oct 25	1.75
Sep 25	1.4
Sep 25	1.34
Sep 25	1.32
Sep 25	1.25
Aug 25	1.24
Aug 25	1.3
Aug 25	1.36
Aug 25	1.26
Aug 25	1.23
Jul 25	1.49
Jul 25	1.3
Jul 25	1.17
Jul 25	1.11
Jun 25	1.05
Jun 25	0.99
Jun 25	0.93
Jun 25	0.71
May 25	0.59
May 25	0.57
May 25	0.59
May 25	0.59
May 25	0.67
Apr 25	0.72
Apr 25	0.68
Apr 25	0.67
Apr 25	0.58
Mar 25	0.64
Mar 25	0.68
Mar 25	0.7
Mar 25	0.65
Feb 25	0.72
Feb 25	0.83
Feb 25	0.89
Feb 25	0.85
Jan 25	0.87
Jan 25	0.95
Jan 25	0.81
Jan 25	0.8
Jan 25	0.86
Dec 24	0.82
Dec 24	0.78
Dec 24	0.77
Dec 24	0.82
Nov 24	0.82
Nov 24	0.75
Nov 24	0.72
Nov 24	0.74
Nov 24	0.72
Oct 24	0.72
Oct 24	0.76

No video analysis for this stock yet. Request one from our team.

News: ABCL

businesswire.com · 2 Sep 2026

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026.

defenseworld.net · 2 Sep 2026

BlackRock Inc. Makes New Investment in AbCellera Biologics Inc. $ABCL

BlackRock Inc. purchased a new position in shares of AbCellera Biologics Inc. (NASDAQ: ABCL) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 3,805,309 shares of the company's stock, valued at approximately $29,872,000. BlackRock Inc. owned 1.25% of AbCellera

benzinga.com · 25 Aug 2026

What'sGoing On With AbCellera Biologics Stock On Tuesday?

AbCellera Biologics Inc. (NASDAQ:ABCL) stock is trading higher on Tuesday. Year-to-date, the stock has jumped over 250%.

seekingalpha.com · 16 Aug 2026

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes

Biotech, especially small-cap names, is experiencing renewed optimism as macro and policy headwinds subside, driving sector-wide rallies. Stabilization at the FDA and a resurgence in M&A and IPO activity are restoring capital flows and investor confidence in biotech equities.

businesswire.com · 13 Aug 2026

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants.

benzinga.com · 12 Aug 2026

What's Going on With AbCellera Biologics Stock On Wednesday?

AbCellera Biologics Inc. (NASDAQ:ABCL) shares are trading higher on Wednesday following the announcement of positive Phase 2 clinical trial results for ABCL635, a single-dose treatment aimed at alleviating menopausal hot flashes.

businesswire.com · 11 Aug 2026

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants.

defenseworld.net · 11 Aug 2026

Investors Buy Large Volume of AbCellera Biologics Call Options (NASDAQ:ABCL)

AbCellera Biologics Inc. (NASDAQ: ABCL - Get Free Report) was the target of unusually large options trading on Monday. Stock investors purchased 16,666 call options on the company. This is an increase of approximately 151% compared to the typical daily volume of 6,636 call options. AbCellera Biologics News Roundup Here are the key news stories impacting